Dr. Weeks’ Comment: “If you can get people to ask the wrong question, then the answer doesn’t matter.” (Thomas Pychon – Gravity’ Rainbow) “Which oncogenes are sensitive to which chemotherapy agents?” is the wrong question since the cancer process (metabolic disorders) creates the genetic aberrations; the oncogenes do NOT create the cancer.
Trying to create a protocol to address oncogenes is treating the symptom as I discussed at length in this lecture given at the Truth about Cancer live symposium in Orlando 2017. Professor Thomas Seyfried champions this position most articulately in the following 2014 article. But when you try and dissuade your oncologist from preforming the standard of care (testing for oncogenes) remember that testing for and treating oncogenes is BIG BUSINESS, so reason alone does not seem to persuade.
“… Tailored therapies, unique to the genomic defects within individual tumors, are viewed as the future of cancer therapeutics ( 2 , 24 ). This therapeutic strategy would certainly be logical if the nuclear somatic mutations detected in tumors were the drivers of the disease. How certain are we that tumors arise from somatic mutations and that some of these mutations drive the disease? It would therefore be important to revisit the origin of the gene theory of cancer…”
“…Advanced metastatic cancers can become manageable when their access to fermentable fuels becomes restricted…”
read the entire article HERE
Further information: watch this YOUTUBE esp at min 44:00 “…In the oncology field they don’t have any idea about it. They don’t even know about it. They dn’t understand the concepts. They are all locked into finding some gene based therapy that doesn’t work and that’s the unfortunate situation we are in today.”
HERE is the NEJM article presenting the rationale for focusing on oncogenes: This is the standard of care and the conventional approach. Now that you have read the minority opinion by Prof. Seyfried, read the majority opinion with the astute minority criticisms in mind.